Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand.

ABSTRACT:

Introduction

The absence of high quality evidence for basic clinical dilemmas in immune thrombocytopenic purpura (ITP) underlines the need for contemporary guidelines relevant to the local treatment context. ITP is diagnosed by exclusions, with a hallmark laboratory finding of isolated thrombocytopenia.

Main recommendations

Bleeding, family and medication histories and a review of historical investigations are required to gauge the bleeding risk and possible hereditary syndromes. Beyond the platelet count, the decision to treat is affected by individual bleeding risk, disease stage, side effects of treatment, concomitant medications, and patient preference. Treatment is aimed at achieving a platelet count > 20 × 10⁹ /L, and avoidance of severe bleeding. Steroids a

SUBMITTER: Choi PY 

PROVIDER: S-EPMC9293212 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature